Burzynski Resh Inst Stock Price, News & Analysis
Company Description
Burzynski Resh Inst (OTC Link: BZYR) is a publicly traded biotechnology company in the Healthcare sector. The company has a market capitalization of $2.6M.
BZYR stock has declined 49.0% over the past year. Shares last traded at $0.0250.
On a trailing twelve-month basis, Burzynski Resh Inst reported revenue of $0 with net income of -$1.4M and diluted earnings per share of $-0.01.
This page provides a comprehensive overview of BZYR stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Burzynski Resh Inst (BZYR) stock last traded at $0.0250. Over the past 12 months, the stock has lost 49.0%. At a market capitalization of $2.6M, BZYR is classified as a micro-cap stock with approximately 131.4M shares outstanding.
Latest News
SEC Filings
Burzynski Resh Inst has filed 3 recent SEC filings, including 2 Form 10-Q, 1 Form 8-K/A. The most recent filing was submitted on January 13, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all BZYR SEC filings →
Financial Highlights
operating income reached -$1.4M, and net income was -$1.4M. Diluted earnings per share stood at $-0.01. The company generated -$389K in operating cash flow.
Upcoming Events
Short Interest History
Short interest in Burzynski Resh Inst (BZYR) currently stands at 285 shares, representing 0.0% of the float. Over the past 12 months, short interest has decreased by 94.9%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Burzynski Resh Inst (BZYR) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed.
BZYR Company Profile & Sector Positioning
Burzynski Resh Inst (BZYR) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the OTC Link.